# A 58-year-old postmenopausal woman presents to the gynecology clinic with a 3-month history of irregular vaginal bleeding. Which assessment finding would be most significant in evaluating for endometrial cancer?

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=540701  
> language: ko  
> subject: Adult Health

## 문제

A 58-year-old postmenopausal woman presents to the gynecology clinic with a 3-month history of irregular vaginal bleeding. Which assessment finding would be most significant in evaluating for endometrial cancer?

## 보기

1. Pelvic pain and cramping
2. Postmenopausal bleeding **✔ 정답**
3. Weight loss and fatigue
4. Urinary frequency and urgency

**정답: 2**

## 해설

Postmenopausal bleeding is the most significant symptom of endometrial cancer, occurring in about 90% of cases. Other symptoms like pelvic pain or urinary issues are less specific and not classic presentations.

## 심화 해설

Clinical Presentation & Significance

A 58-year-old postmenopausal woman with a 3-month history of irregular vaginal bleeding presents a classic clinical scenario. The most significant assessment finding for evaluating endometrial cancer in this context is postmenopausal bleeding (PMB). While the patient’s chief complaint is irregular bleeding, recognizing this symptom specifically as PMB—any vaginal bleeding occurring after 12 months of amenorrhea—is the critical first step in risk stratification. Updated clinical guidance emphasizes that PMB is the cardinal presenting symptom of endometrial cancer, and the primary role of initial assessment is to triage these patients for further diagnostic evaluation [2].

Pathophysiology & Clinical Reasoning

Endometrial cancer arises from the glandular tissue of the uterine lining, often driven by unopposed estrogen stimulation, which leads to endometrial proliferation, hyperplasia, and eventually malignant transformation. As the neoplastic tissue outgrows its blood supply or invades local vasculature, it becomes friable and prone to spontaneous, irregular shedding, which manifests clinically as postmenopausal bleeding. This symptom is the most common and earliest indicator of endometrial malignancy, reported in over 90% of cases . The other listed symptoms—pelvic pain, weight loss, fatigue, and urinary frequency—are more indicative of advanced or metastatic disease, where the tumor mass exerts pressure on adjacent pelvic structures or systemic effects of malignancy occur. Therefore, in the initial evaluation, the presence of PMB itself is the most significant finding that directly prompts the diagnostic pathway, which historically relied on transvaginal ultrasound (TVUS) to measure endometrial thickness (ET) [2].

Diagnostic Nuance & Evidence Update

A crucial nuance for NCLEX-RN preparation is understanding the limitations of the traditional triage tool. While an endometrial thickness of ≤4 mm on TVUS was previously considered sufficient to exclude cancer with high sensitivity, recent evidence has challenged this. A retrospective cohort study found that certain aggressive subtypes, particularly non-endometrioid histologies like serous carcinoma, can present with a thin endometrial stripe, even when controlling for cases with incomplete visualization [1]. This means a thin endometrium on ultrasound does not reliably rule out malignancy in all patients. Consequently, updated ACOG guidance now recommends a combined approach of TVUS and endometrial sampling for the evaluation of most patients with PMB, moving away from using ultrasound alone as a definitive triage tool [2]. This shift is reinforced by research showing the low specificity of TVUS, which leads to many invasive follow-up procedures, and its potential to miss up to a quarter of high-risk serous cancers . The definitive diagnosis of endometrial cancer is made through histopathological evaluation of an endometrial tissue sample obtained via biopsy, dilation and curettage, or hysterectomy .References (research sources)

- [1]Endometrial thickness in patients with postmenopausal bleeding and endometrial cancer: A retrospective cohort study.Research articleLiu J, Nolin AC, Unnithan S, Erkanli A, Penvose K, Atkins S, Holtzman S, Chess I, Vattakalam A, Blank SV, Wright JD, Albright BB, Hazelton WD, Myers ER, Havrilesky LJ. (2026) · DOI: 10.1016/j.gore.2026.102135

- [2]Updated Guidance Regarding The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Individuals With Postmenopausal Bleeding.Research article(2026) · DOI: 10.1097/aog.0000000000006275

## 임상 시나리오

Postmenopausal Bleeding EvaluationTriage and Diagnostic Workup for Endometrial Cancer
Postmenopausal bleeding is defined as any vaginal bleeding after 12 months of amenorrhea and is the cardinal symptom of endometrial cancer, present in over 90% of cases. The initial assessment must triage these patients for immediate diagnostic evaluation.

The standard first-line diagnostic test is a transvaginal ultrasound to measure endometrial thickness. An endometrial stripe thickness of ≤4 mm has a high negative predictive value and generally rules out cancer, while a thickness >4 mm requires an endometrial biopsy for histologic diagnosis.

CautionSymptoms like pelvic pain, weight loss, or urinary frequency often suggest advanced or metastatic disease. Do not rely on these for early detection; any report of postmenopausal bleeding warrants prompt investigation regardless of other symptoms.

## 핵심 개념

- **Postmenopausal Bleeding** — Any vaginal bleeding occurring after 12 consecutive months of amenorrhea; the cardinal symptom for endometrial cancer evaluation.
- **Endometrial Cancer** — Malignancy of the uterine lining, often presenting early with postmenopausal bleeding due to abnormal endometrial proliferation.

## 같은 주제 문제

- [A 58-year-old postmenopausal woman presents to the clinic with a 3-month history of irregu…](https://mymerci.kr/pages/nclex_q.php?qn_id=540699)
- [A 62-year-old postmenopausal woman presents to the clinic with a 2-month history of postco…](https://mymerci.kr/pages/nclex_q.php?qn_id=540700)
- [A 62-year-old postmenopausal woman is scheduled for a total abdominal hysterectomy with bi…](https://mymerci.kr/pages/nclex_q.php?qn_id=540702)
- [A 55-year-old postmenopausal woman diagnosed with stage II endometrial cancer is scheduled…](https://mymerci.kr/pages/nclex_q.php?qn_id=540703)
- [A 58-year-old postmenopausal woman is scheduled for a total abdominal hysterectomy with bi…](https://mymerci.kr/pages/nclex_q.php?qn_id=540704)
- [A 70-year-old postmenopausal woman with multiple comorbidities has been diagnosed with sta…](https://mymerci.kr/pages/nclex_q.php?qn_id=540705)

---

More free questions: [기출문제](https://mymerci.kr/)

_학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요._